The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials

BACKGROUND: Diabetes mellitus (DM) is a global health problem, and it has become a shocking threat in the contemporary era. The objective of this study was to analyze the safety of sotagliflozin in patients with DM systematically and intuitively. METHODS: On November 15, 2021, literature retrieval w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Feifei, Du, Nannan, Zhou, Lulin, Wang, Chenxi, Ren, He, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548998/
https://www.ncbi.nlm.nih.gov/pubmed/36225203
http://dx.doi.org/10.3389/fendo.2022.968478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548998/
https://www.ncbi.nlm.nih.gov/pubmed/36225203
http://dx.doi.org/10.3389/fendo.2022.968478

Ejemplares similares